ArticleBMC cardiovascular disorders2025
Prevalence and factors associated with cardiometabolic multimorbidity: a cross-sectional study in older adults of the first Brazilian hypertension registry.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Asia at the Epicenter of the Global Cardiometabolic Shift.JACC. Asia · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundCardiometabolic multimorbidity (CM-MM) is defined as the coexistence of at least two of the following conditions: diabetes mellitus (DM), myocardial infarction (MI), or stroke (ST). Data on the prevalence of CM-MM and its associated factors are scarce in Brazil.
objectivesTo analyse the prevalence of CM-MM and its associated factors in a population of Brazilian adults aged ≥ 65 years with hypertension.
methodsWe conducted an analytical cross-sectional study from 2013 to 2015 using data from the first Brazilian Hypertension Registry (BHR). Participants were recruited from 45 public and private healthcare services in all regions of Brazil. CM-MM was the main outcome measure, analysed according to clinical and sociodemographic factors. Descriptive and association analyses were performed to compare CM-MM and the other parameters.
resultsWe analysed data from 1,033 individuals. The prevalence of CM-MM was 8.9%, with higher rates among males, participants self-declared as White, and those in the 65-69 years age group. DM (32.7%) was the most prevalent single condition. Dyslipidaemia (70.7%), obesity (62%), and uncontrolled blood pressure (44.6%) were also common. Among the combinations of conditions, DM + MI was the most frequent (5.6%). After adjustment, CM-MM was associated with being male, having dyslipidaemia, experiencing heart failure, and undergoing coronary artery bypass graft surgery. Chronic kidney disease was not associated with CM-MM.
conclusionsThe prevalence of CM-MM in older people with hypertension was approximately 9%. CM-MM was associated with risk factors such as dyslipidaemia and obesity. These findings show the importance of comprehensive cardiometabolic management to reduce the incidence of CM-MM in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.